Rapid Switching Between Transdermal Fentanyl and Methadone in Cancer Patients
- 1 August 2005
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (22) , 5229-5234
Abstract
Purpose The aim of this study was to examine the clinical effects of switching from transdermal (TTS) fentanyl to methadone, or vice versa, in patients with a poor response to the previous opioid. Patients and Methods A prospective study was carried out on 31 patients who switched from TTS fentanyl to oral methadone, or vice versa, because of poor opioid response. A fixed conversion ratio of fentanyl to methadone of 1:20 was started and assisted by rescue doses of opioids, and then doses were changed according to clinical response. Pain and symptom intensity, expressed as distress score, were recorded before switching doses of the two opioids and after subsequent doses. The number of changes of the daily doses, time to achieve stabilization, and hospital stay were also recorded. Results Eighteen patients were switched from TTS fentanyl to methadone, and seven patients were switched from methadone to TTS fentanyl. A significant decrease in pain and symptom intensity, expressed as symptom distress score, was found within 24 hours after switching took place in both directions. Unsuccessful switching occurred in six patients, who were subsequently treated with an alternative therapy. Conclusion A rapid switching using an initial fixed ratio of fentanyl to methadone of 1:20 is an effective method to improve the balance between analgesia and adverse effects in cancer patients with poor response to the previous opioid. No relationship between the final opioid dose and the dose of the previous opioid has been found.Keywords
This publication has 21 references indexed in Scilit:
- An ad libitum schedule for conversion of morphine to methadone in advanced cancer patients: an open uncontrolled prospective study in a Chinese populationPalliative Medicine, 2003
- Switching From Morphine to Methadone to Improve Analgesia and Tolerability in Cancer Patients: A Prospective StudyJournal of Clinical Oncology, 2001
- Opioid rotation for cancer painCancer, 1999
- Rapid Switching From Morphine to Methadone in Cancer Patients With Poor Response to MorphineJournal of Clinical Oncology, 1999
- Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?Journal of Clinical Oncology, 1998
- Dose ratio between morphine and methadone in patients with cancer painCancer, 1998
- Methadone in cancer painEuropean journal of pain, 1997
- Opioid rotation in patients with cancer pain: A retrospective comparison of dose ratios between methadone, hydromorphone, and morphineCancer, 1996
- Day-to-day titration to initiate transdermal fentanyl in patients with cancer pain: Short- and long-term experiences in a prospective study of 39 patientsJournal of Pain and Symptom Management, 1996
- Individual variability in the response to different opioids: report of five casesPain, 1992